Reuters logo
BRIEF-Biopharmx says achieved primary endpoint in trial of treatment for acne
May 3, 2017 / 9:34 PM / 7 months ago

BRIEF-Biopharmx says achieved primary endpoint in trial of treatment for acne

May 3 (Reuters) - Biopharmx Corp

* Biopharmx Corp says achieved primary endpoint in its phase 2b clinical trial evaluating bpx-01

* Biopharmx Corp says based on these phase 2b results, Biopharmx continues to progress bpx-01 towards a phase 3 program Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below